Sofinnova Partners collects $340 mln for initial healthcare crossover fund
Sofinnova Partners, a European life sciences-focused venture firm, has raised $340 million for its inaugural healthcare crossover fund. Sofinnova Crossover I will invest in the biopharmaceutical and medical device sectors. The fund's limited partners include sovereign funds, insurance companies, corporations and family offices. Triago was the placement agent for the fund while Clifford Chance provided legal counsel.
4 April 2018•2 mins read
